A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP

Purpose. Docetaxel/5-FU/CDDP (DFP) therapy is a useful treatment for advanced esophageal cancer. However, adverse reactions such as chemotherapy-induced nausea and vomiting (CINV) interfere often with continuation of the chemotherapy. We investigated the efficacy of rikkunshito (TJ-43) on CINV. Meth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Seike, Junichi, Sawada, Toru, Kawakita, Naoya, Yamamoto, Yota, Yuasa, Yasuhiro, Yamai, Hiromichi, Takachi, Hirokazu, Yoshida, Takahiro, Tangoku, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2011
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3263686/
https://ncbi.nlm.nih.gov/pubmed/22312520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/715623
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados